Literature DB >> 1726610

Reduced tenascin expression in colonic carcinoma with lymphogenous metastasis.

I Sugawara1, J Hirakoshi, A Masunaga, S Itoyama, T Sakakura.   

Abstract

We have studied expression of tenascin (TN) in colonic carcinoma cells from 81 patients with colonic carcinoma without (20) and with (61) lymphogenous metastases, in order to assess whether TN plays a role in local invasiveness and metastasis of tumors. In metastatic colonic carcinoma tissues from 52 cases, moderate, partial expression of TN was observed in the primary foci but no TN expression was observed in tissues from 9 others. However, in every case of nonmetastatic colonic carcinoma, very strong TN expression was observed in the tissues. Furthermore, the presence of dense TN accumulation correlated well with the prognoses (1-year survival) of colonic cancer patients (p less than 0.01). Weak TN expression was observed in 24/61 of the metastatic lymph nodes examined. In 2 patients with metastatic colonic carcinoma, the colonic cancer cells produced TN. TN may, therefore, play a role in limiting or preventing local tumor invasion rather than preventing metastasis and is a useful marker for predicting the prognoses of patients with colonic cancer.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1726610

Source DB:  PubMed          Journal:  Invasion Metastasis        ISSN: 0251-1789


  7 in total

1.  Tenascin immunoreactivity in the large bowel and the liver in patients with colorectal cancer.

Authors:  M V Gulubova; T Vlaykova
Journal:  Histochem J       Date:  2001-02

2.  Tenascin-C in primary Merkel cell carcinoma.

Authors:  V Koljonen; T Jahkola; E Tukiainen; G Granroth; C Haglund; T Böhling
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

3.  Prognostic significance of tenascin-C expression in superficial and invasive bladder cancer.

Authors:  A Brunner; C Mayerl; A Tzankov; I Verdorfer; I Tschörner; H Rogatsch; G Mikuz
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

4.  Expression of nm23-H1 gene product in thyroid, ovary, and breast cancers.

Authors:  T Okubo; S Inokuma; S Takeda; S Itoyama; K Kinoshita; I Sugawara
Journal:  Cell Biophys       Date:  1995-06

5.  Stromal tenascin distribution as a prognostic marker in colorectal cancer.

Authors:  U Kressner; G Lindmark; B Tomasini-Johansson; R Bergström; B Gerdin; L Påhlman; B Glimelius
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 6.  Tenascin-C: Form versus function.

Authors:  Sean P Giblin; Kim S Midwood
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

7.  Relationships among tenascin expression, DNA ploidy patterns, and multidrug resistance gene product (P-glycoprotein) in human colon carcinoma.

Authors:  I Sugawara; J Hirakoshi; M Kusakabe; A Masunaga; S Itoyama; T Sakakura
Journal:  Jpn J Cancer Res       Date:  1993-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.